[Occurrence of gynecomastia during prolonged pulsatile administration of gonadorelin].
Lefebvre
H
H
Kuhn
J M
JM
Wolf
L M
LM
D000328:Adult; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects*; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011673:Pulsatile Flow; D013997:Time Factors
D007987:Gonadotropin-Releasing Hormone
Apparition d'une gynécomastie au cours de l'administration pulsatile prolongée de gonadoreline.